Clinical Trials List
2023-01-05 - 2026-12-13
Phase III
Recruiting5
ICD-10B18.1
Chronic viral hepatitis B without delta-agent
ICD-9070.32
Viral hepatitis B without mention of hepatic coma, chronic, without mention of hepatitis delta
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chun-Yen Lin NA
- Chien-Hao Huang NA
- 戴達英 NA
- I-Shyan Sheen NA
- 陳正仁 NA
- 滕威 NA
- Rong-Nan Chien NA
- Chao-Wei Hsu NA
- 劉彦君 NA
- Yi-Chung Hsieh NA
- 林伯庭 NA
- Yi-Cheng Chen NA
- 鄭雅婷 NA
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 呂宜達 NA
- 林宛姿 NA
- 李少武 NA
- 黃儀倢 NA
- 蔡炘儒 NA
- Sheng-Shun Yang NA
- TENG-YU LEE NA
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Lun Yeh NA
- Jee-Fu Huang NA
- Ming-Lung Yu NA
- 黃駿逸 NA
- 梁博程 NA
- Chung-Feng Huang NA
- Chia-Yen Dai NA
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50~100 participants
-
Global
750~1050 participants
